Drug details
Fiasp (insulin aspart injection for subcutaneous or intravenous use)
type of Antidiabetics, Insulins, Antidiabetics, Rapid-Acting Insulins
Fiasp (insulin aspart injection) is a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- confusion,
- tiredness,
- stomach pain,
- dizziness,
- blurred vision,
- dry mouth,
- headache,
- sweating,
- increased urination,
- fruity breath odor,
- loss of consciousness
- increased hunger or thirst,
- anxiety,
- feeling cold,
- dry skin,
- shakiness,
- increased hunger,
- unusually weakness,
- irritable,
- fast heartbeat, and
The following drugs are related to Fiasp, either as a replacement or used together:
- Diabinese (chlorpropamide)
- Zegalogue (dasiglucagon injection)
- Lantidra (donislecel-jujn allogeneic pancreatic islet cellular)
- Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets)
- Glucotrol (glipizide)
- Lyumjev (insulin lispro-aabc injection)
- Invega (paliperidone)
- Mounjaro (tirzepatide injection)
- Starlix Tablet (nateglinide)
- Prandin (repaglinide)
- Tzield (teplizumab-mzwv injection, for intravenous use)